P. Kunicki

发表

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

U. Christians, H. Colom, V. Haufroid, 2019, Therapeutic drug monitoring.

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

U. Christians, P. Marquet, C. Seger, 2016, Therapeutic drug monitoring.

Apolipoprotein E polymorphism and low density lipoprotein (LDL) oxidation in patients with dementia.

D. Ryglewicz, M. Rodo, W. Lojkowska, 2003, Folia neuropathologica.

Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome

A. Witkowski, P. Kunicki, Z. Chmielak, 2016, BMC Cardiovascular Disorders.

Patency of infarct-related artery and platelet reactivity in patients with ST-segment elevation myocardial infarction

J. Wąs, A. Witkowski, W. Rużyłło, 2013 .

Higher efficacy of oral nitrendipine admininstration in comparison with sublingual route . Pharmacokinetic and pharmacodynamic evaluation in hypertensive urgencies

I. Kowalik, H. Szwed, R. Dąbrowski, 2005 .

Simple HPLC method for cefazolin determination in human serum - validation and stability testing.

J. Wąs, P. Kunicki, J. Waś, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Isotope-labeled versus analog internal standard in LC-MS/MS method for tacrolimus determination in human whole blood samples - A compensation of matrix effects.

P. Kunicki, T. Pawiński, Magdalena Bodnar-Broniarczyk, 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

N-Acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances

A. Pawlik, P. Kunicki, J. Wójcicki, 1997, European Journal of Clinical Pharmacology.

Simple and sensitive high-performance liquid chromatographic method for the determination of 1,5-benzodiazepine clobazam and its active metabolite N-desmethylclobazam in human serum and urine with application to 1,4-benzodiazepines analysis.

P. Kunicki, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

P. Marquet, C. Seger, K. Budde, 2016, Therapeutic drug monitoring.

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

V. Haufroid, A. Åsberg, B. Tönshoff, 2021, Therapeutic drug monitoring.

Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method.

P. Kunicki, T. Pawiński, K. Sikorska, 2017, Biomedical chromatography : BMC.

Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary?

P. Kunicki, Aleksandra Wróbel, 2021, Molecules.

A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients

P. Kunicki, T. Pawiński, Magdalena Bodnar-Broniarczyk, 2015, Therapeutic drug monitoring.

Validation of an assay for quantification of free normetanephrine, metanephrine and methoxytyramine in plasma by high performance liquid chromatography with coulometric detection: Comparison of peak-area vs. peak-height measurements.

P. Kunicki, D. Nieć, 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients—implications for therapeutic drug monitoring

M. Durlik, M. Hurkacz, P. Kunicki, 2018, European Journal of Clinical Pharmacology.

Debrisoquine hydroxylation in a Polish population

A. Pawlik, P. Kunicki, B. Gawrońska-Szklarz, 2004, European Journal of Clinical Pharmacology.

Determination of loratadine in human plasma by high-performance liquid chromatographic method with ultraviolet detection.

P. Kunicki, 2001, Journal of chromatography. B, Biomedical sciences and applications.

High performance liquid chromatographic analysis of some antiarrhythmic drugs in human serum using cyanopropyl derivatized silica phase

P. Kunicki, D. Sitkiewicz, 1996 .

43 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF SOME ANTIARRHYTHMIC DRUGS USING CYANOPROPYL DERIVATIZED SILICA PHASE

P. Datta, H. Leonard, P. Kunicki, 1995 .

High-performance liquid chromatographic method for the simultaneous determination of propafenone and 5-hydroxypropafenone in human serum.

P. Kunicki, D. Sitkiewicz, D. Pączkowski, 1992, Polish journal of pharmacology and pharmacy.

Generic Medicinal Products in Immunosuppressive Therapy—Should It be a Challenge for Therapeutic Drug Monitoring?

P. Kunicki, T. Pawiński, Arkadiusz Kocur, 2023, Therapeutic drug monitoring.

Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients

A. Witkowski, P. Kunicki, Z. Chmielak, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prediction of Free Mycophenolic Acid Concentrations and Free Fraction in Adult Lupus Nephritis Patients.

P. Kunicki, T. Pawiński, Paulina Łuszczyńska, 2019, Therapeutic Drug Monitoring.

Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients—implications for therapeutic drug monitoring

M. Durlik, M. Hurkacz, P. Kunicki, 2018, European Journal of Clinical Pharmacology.

Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.

M. Sobieszczańska-Małek, P. Kunicki, 2005, Therapeutic Drug Monitoring.

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

P. Marquet, C. Seger, K. Budde, 2016, Therapeutic drug monitoring.

Simple HPLC method for cefazolin determination in human serum - validation and stability testing.

P. Kunicki, J. Waś, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.